NBI components
The NASDAQ Biotechnology constituents can be found in the table below. Sort NBI stock components by various financial metrics and data such as performance, dividends, income statement and balance sheet.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AZNAstraZeneca PLCDR | 239.321 B USD | 77.20 USD | +0.30% | 1.578 M | 0.29 | 38.05 | 2.03 USD | +34.44% | 1.84% | Health Technology | Buy |
 AMGNAmgen Inc. | 169.006 B USD | 315.06 USD | −1.25% | 983.16 K | 0.28 | 45.05 | 6.99 USD | −52.48% | 2.71% | Health Technology | Buy |
 SNYSanofiDR | 123.98 B USD | 48.90 USD | −0.22% | 1.304 M | 0.65 | 21.05 | 2.32 USD | −20.45% | 2.81% | Commercial Services | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 113.155 B USD | 438.50 USD | +0.23% | 439.684 K | 0.38 | 28.45 | 15.41 USD | +22.79% | 0.00% | Health Technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 107.321 B USD | 974.16 USD | −0.41% | 111.511 K | 0.24 | 28.78 | 33.85 USD | −8.04% | 0.00% | Health Technology | Buy |
 GILDGilead Sciences, Inc. | 84.618 B USD | 67.92 USD | +1.36% | 1.321 M | 0.20 | 189.35 | 0.36 USD | −91.89% | 4.51% | Health Technology | Buy |
 MRNAModerna, Inc. | 50.749 B USD | 132.42 USD | +2.60% | 1.545 M | 0.35 | — | −15.68 USD | −235.29% | 0.00% | Health Technology | Buy |
 BIIBBiogen Inc. | 33.568 B USD | 230.56 USD | −2.02% | 380.702 K | 0.35 | 28.80 | 8.01 USD | −62.82% | 0.00% | Health Technology | Buy |
 ARGXargenx SEDR | 22.312 B USD | 376.24 USD | −0.19% | 59.071 K | 0.19 | — | −5.17 USD | +34.20% | 0.00% | Health Technology | Buy |
 BNTXBioNTech SEDR | 21.918 B USD | 93.00 USD | +0.87% | 175.976 K | 0.34 | 194.28 | 0.48 USD | −98.13% | 0.00% | Health Technology | Neutral |
 GMABGenmab A/SDR | 19.809 B USD | 29.78 USD | −1.46% | 310.081 K | 0.56 | 24.69 | 1.21 USD | +8.61% | 0.00% | Health Technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 18.745 B USD | 148.19 USD | +0.54% | 376.523 K | 0.83 | — | −2.68 USD | +69.18% | 0.00% | Health Technology | Buy |
 ILMNIllumina, Inc. | 18.312 B USD | 114.95 USD | −0.05% | 308.03 K | 0.15 | — | −8.15 USD | +71.48% | 0.00% | Health Technology | Neutral |
 BGNEBeiGene, Ltd.DR | 17.843 B USD | 170.20 USD | +3.23% | 117.475 K | 0.67 | — | −7.57 USD | +59.27% | 0.00% | Health Technology | Strong buy |
 RPRXRoyalty Pharma plc | 16.671 B USD | 27.91 USD | −1.08% | 1.163 M | 0.39 | 15.67 | 1.78 USD | +134.91% | 2.87% | Health Technology | Strong buy |
 BMRNBioMarin Pharmaceutical Inc. | 14.716 B USD | 77.50 USD | −3.61% | 1.378 M | 1.02 | 72.53 | 1.07 USD | +187.23% | 0.00% | Health Technology | Buy |
 NBIXNeurocrine Biosciences, Inc. | 14.147 B USD | 140.57 USD | −1.00% | 191.722 K | 0.29 | 38.64 | 3.64 USD | +497.14% | 0.00% | Health Technology | Buy |
 VTRSViatris Inc. | 13.27 B USD | 11.15 USD | +0.68% | 2.608 M | 0.30 | — | −0.05 USD | −103.19% | 4.34% | Health Technology | Neutral |
 INCYIncyte Corporation | 12.691 B USD | 56.52 USD | −0.93% | 1.405 M | 0.54 | 17.15 | 3.29 USD | +127.60% | 0.00% | Health Technology | Buy |
 MEDPMedpace Holdings, Inc. | 12.377 B USD | 399.46 USD | −1.58% | 44.311 K | 0.21 | 40.70 | 9.82 USD | +24.38% | 0.00% | Commercial Services | Buy |
 SRPTSarepta Therapeutics, Inc. | 12.376 B USD | 130.93 USD | −1.19% | 302.433 K | 0.24 | 1968.80 | 0.07 USD | — | 0.00% | Health Technology | Strong buy |
 UTHRUnited Therapeutics Corporation | 12.097 B USD | 272.66 USD | −0.01% | 117.447 K | 0.22 | 12.89 | 21.15 USD | +42.36% | 0.00% | Health Technology | Buy |
 ROIVRoivant Sciences Ltd. | 9.191 B USD | 11.41 USD | −0.83% | 826.801 K | 0.25 | 2.19 | 5.21 USD | — | 0.00% | Health Technology | Strong buy |
 LEGNLegend Biotech CorporationDR | 8.341 B USD | 45.66 USD | −0.22% | 269.539 K | 0.32 | — | −2.60 USD | −11.33% | 0.00% | Health Technology | Strong buy |
 PCVXVaxcyte, Inc. | 8.011 B USD | 73.64 USD | +2.80% | 371.99 K | 0.66 | — | −4.36 USD | −25.83% | 0.00% | Health Technology | Strong buy |
 ITCIIntra-Cellular Therapies Inc. | 7.033 B USD | 66.62 USD | −0.33% | 162.497 K | 0.19 | — | −1.15 USD | +52.23% | 0.00% | Health Technology | Strong buy |
 ASNDAscendis Pharma A/SDR | 7.022 B USD | 123.17 USD | −0.71% | 185.077 K | 0.36 | — | −9.26 USD | +14.73% | 0.00% | Health Technology | Strong buy |
 JAZZJazz Pharmaceuticals plc | 6.928 B USD | 109.90 USD | +0.15% | 240.442 K | 0.33 | 23.91 | 4.60 USD | — | 0.00% | Health Technology | Buy |
 BPMCBlueprint Medicines Corporation | 6.702 B USD | 107.04 USD | +0.23% | 81.627 K | 0.11 | — | −4.82 USD | +50.35% | 0.00% | Health Technology | Buy |
 GRFSGrifols, S.A.DR | 6.629 B USD | 7.64 USD | −0.65% | 410.337 K | 0.25 | 30.46 | 0.25 USD | −74.09% | 0.00% | Health Technology | Neutral |
 RVMDRevolution Medicines, Inc. | 6.523 B USD | 39.53 USD | +0.37% | 377.818 K | 0.34 | — | −3.76 USD | −23.63% | 0.00% | Health Technology | Strong buy |
 CYTKCytokinetics, Incorporated | 6.302 B USD | 60.10 USD | −0.66% | 184.172 K | 0.12 | — | −5.40 USD | −17.98% | 0.00% | Health Technology | Strong buy |
 EXELExelixis, Inc. | 6.133 B USD | 21.06 USD | −0.31% | 739.674 K | 0.34 | 32.56 | 0.65 USD | +36.96% | 0.00% | Health Technology | Buy |
 HALOHalozyme Therapeutics, Inc. | 5.777 B USD | 45.39 USD | −0.94% | 288.289 K | 0.24 | 18.77 | 2.42 USD | +85.23% | 0.00% | Health Technology | Strong buy |
 BBIOBridgeBio Pharma, Inc. | 5.775 B USD | 30.86 USD | +2.97% | 743.487 K | 0.60 | — | −3.23 USD | −13.87% | 0.00% | Health Technology | Strong buy |
 IONSIonis Pharmaceuticals, Inc. | 5.437 B USD | 37.25 USD | −5.00% | 1.857 M | 1.66 | — | −2.67 USD | −15.53% | 0.00% | Health Technology | Buy |
 IBRXImmunityBio, Inc. | 5.371 B USD | 7.77 USD | −4.12% | 2.083 M | 0.27 | — | −1.05 USD | +0.05% | 0.00% | Health Technology | Buy |
 APLSApellis Pharmaceuticals, Inc. | 4.984 B USD | 41.07 USD | −2.03% | 194.986 K | 0.12 | — | −3.46 USD | +44.89% | 0.00% | Health Technology | Strong buy |
 NUVLNuvalent, Inc. | 4.787 B USD | 74.16 USD | +3.45% | 150.386 K | 0.41 | — | −2.41 USD | −40.04% | 0.00% | Health Technology | Strong buy |
 CRSPCRISPR Therapeutics AG | 4.736 B USD | 55.78 USD | −2.08% | 532.686 K | 0.33 | — | −2.72 USD | +59.50% | 0.00% | Health Technology | Buy |
 KRYSKrystal Biotech, Inc. | 4.662 B USD | 163.25 USD | +0.04% | 64.267 K | 0.21 | 86.72 | 1.88 USD | — | 0.00% | Health Technology | Strong buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 4.582 B USD | 215.00 USD | +1.54% | 64.798 K | 0.15 | — | −23.08 USD | −27.58% | 0.00% | Health Technology | Strong buy |
 IMVTImmunovant, Inc. | 4.51 B USD | 31.04 USD | +0.36% | 70.183 K | 0.09 | — | −1.83 USD | −10.48% | 0.00% | Health Technology | Strong buy |
 ALPNAlpine Immune Sciences, Inc. | 4.456 B USD | 64.96 USD | −0.02% | 371.932 K | 0.21 | — | −0.69 USD | +59.41% | 0.00% | Health Technology | Neutral |
 ALKSAlkermes plc | 4.102 B USD | 24.24 USD | +0.41% | 382.499 K | 0.26 | 9.56 | 2.54 USD | — | 0.00% | Health Technology | Buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 4.059 B USD | 51.47 USD | +1.94% | 171.644 K | 0.18 | — | −3.77 USD | −15.15% | 0.00% | Health Technology | Strong buy |
 HCMHUTCHMED (China) LimitedDR | 3.843 B USD | 20.95 USD | −2.78% | 51.244 K | 0.32 | 36.45 | 0.57 USD | — | 0.00% | Health Technology | Strong buy |
 INSMInsmed Incorporated | 3.724 B USD | 25.06 USD | +0.52% | 260.091 K | 0.15 | — | −5.24 USD | −22.78% | 0.00% | Health Technology | Strong buy |
 AXSMAxsome Therapeutics, Inc. | 3.634 B USD | 76.51 USD | +0.76% | 137.029 K | 0.21 | — | −6.38 USD | −67.92% | 0.00% | Health Technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 3.539 B USD | 42.57 USD | +3.53% | 568.264 K | 0.78 | — | −8.03 USD | +21.74% | 0.00% | Health Technology | Strong buy |
 SWTXSpringWorks Therapeutics, Inc. | 3.363 B USD | 45.39 USD | +0.42% | 267.496 K | 0.27 | — | −4.99 USD | +3.03% | 0.00% | Health Technology | Strong buy |
 GHGuardant Health, Inc. | 3.316 B USD | 27.10 USD | +5.22% | 1.421 M | 0.56 | — | −3.92 USD | +39.62% | 0.00% | Health Services | Strong buy |
 IDYAIDEAYA Biosciences, Inc. | 3.161 B USD | 41.77 USD | −1.58% | 132.745 K | 0.26 | — | −2.00 USD | −31.42% | 0.00% | Health Technology | Strong buy |
 APGEApogee Therapeutics, Inc. | 3.151 B USD | 53.90 USD | +1.13% | 197.123 K | 0.45 | — | — | — | 0.00% | Health Technology | Strong buy |
 SMMTSummit Therapeutics Inc. | 3.103 B USD | 4.42 USD | −1.56% | 498.146 K | 0.22 | — | −0.17 USD | +90.98% | 0.00% | Health Technology | Strong buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 3.101 B USD | 24.97 USD | −0.28% | 352.968 K | 0.29 | — | −4.24 USD | −196.76% | 0.00% | Health Technology | Buy |
 XENEXenon Pharmaceuticals Inc. | 3.043 B USD | 40.32 USD | −0.33% | 182.016 K | 0.69 | — | −2.71 USD | −16.58% | 0.00% | Health Technology | Strong buy |
 DNLIDenali Therapeutics Inc. | 2.972 B USD | 20.84 USD | −0.10% | 250.31 K | 0.23 | — | −0.97 USD | +66.23% | 0.00% | Health Technology | Strong buy |
 IOVAIovance Biotherapeutics, Inc. | 2.97 B USD | 10.62 USD | −0.61% | 1.702 M | 0.25 | — | −1.82 USD | +24.46% | 0.00% | Health Technology | Strong buy |
 MRVIMaravai LifeSciences Holdings, Inc. | 2.849 B USD | 11.31 USD | +0.98% | 967.531 K | 0.41 | — | −0.99 USD | −186.08% | 0.00% | Health Technology | Buy |
 ACLXArcellx, Inc. | 2.814 B USD | 52.60 USD | +1.70% | 200.986 K | 0.43 | — | −1.06 USD | +75.18% | 0.00% | Health Technology | Strong buy |
 FOLDAmicus Therapeutics, Inc. | 2.811 B USD | 9.49 USD | −1.76% | 603.027 K | 0.21 | — | −0.50 USD | +30.03% | 0.00% | Health Technology | Strong buy |
 IMCRImmunocore Holdings plcDR | 2.801 B USD | 54.82 USD | −2.12% | 144.895 K | 0.33 | — | −1.21 USD | −13.16% | 0.00% | Health Technology | Strong buy |
 RNAAvidity Biosciences, Inc. | 2.784 B USD | 29.11 USD | −1.36% | 431.902 K | 0.43 | — | −2.95 USD | +12.25% | 0.00% | Health Technology | Strong buy |
 TWSTTwist Bioscience Corporation | 2.763 B USD | 47.46 USD | −1.87% | 199.112 K | 0.12 | — | −3.35 USD | +11.09% | 0.00% | Health Technology | Buy |
 MRUSMerus N.V. | 2.647 B USD | 45.10 USD | −0.24% | 223.619 K | 0.33 | — | −2.72 USD | +17.30% | 0.00% | Health Technology | Strong buy |
 PTCTPTC Therapeutics, Inc. | 2.603 B USD | 33.94 USD | +0.83% | 132.651 K | 0.19 | — | −7.69 USD | +2.63% | 0.00% | Health Technology | Neutral |
 NTLAIntellia Therapeutics, Inc. | 2.524 B USD | 26.16 USD | −0.23% | 436.258 K | 0.30 | — | −5.37 USD | +0.38% | 0.00% | Health Technology | Buy |
 FTREFortrea Holdings Inc. | 2.504 B USD | 28.02 USD | −2.61% | 685.786 K | 0.33 | — | −1.39 USD | — | 0.00% | Commercial Services | Buy |
 ACADACADIA Pharmaceuticals Inc. | 2.459 B USD | 14.89 USD | −1.55% | 427.234 K | 0.19 | — | −0.02 USD | +98.26% | 0.00% | Health Technology | Buy |
 JANXJanux Therapeutics, Inc. | 2.459 B USD | 47.42 USD | −0.13% | 144.875 K | 0.14 | — | −1.22 USD | +24.13% | 0.00% | Health Technology | Strong buy |
 RYTMRhythm Pharmaceuticals, Inc. | 2.397 B USD | 39.32 USD | −0.72% | 57.187 K | 0.09 | — | −4.64 USD | −37.91% | 0.00% | Health Technology | Strong buy |
 NVCRNovoCure Limited | 2.361 B USD | 21.94 USD | +4.23% | 451.88 K | 0.32 | — | −1.81 USD | −34.69% | 0.00% | Health Technology | Buy |
 VCELVericel Corporation | 2.327 B USD | 47.87 USD | −3.12% | 126.347 K | 0.32 | — | −0.01 USD | +98.56% | 0.00% | Health Technology | Strong buy |
 DYNDyne Therapeutics, Inc. | 2.316 B USD | 28.55 USD | −2.83% | 533.873 K | 0.71 | — | −3.97 USD | −18.88% | 0.00% | Health Technology | Strong buy |
 VERAVera Therapeutics, Inc. | 2.309 B USD | 42.05 USD | −1.50% | 131.138 K | 0.18 | — | −2.04 USD | +40.28% | 0.00% | Health Technology | Strong buy |
 GERNGeron Corporation | 2.293 B USD | 3.87 USD | −0.88% | 2.188 M | 0.32 | — | −0.35 USD | −0.29% | 0.00% | Health Technology | Strong buy |
 RXRXRecursion Pharmaceuticals, Inc. | 2.268 B USD | 9.55 USD | −4.60% | 2.695 M | 0.45 | — | −1.60 USD | −16.02% | 0.00% | Health Technology | Buy |
 ARVNArvinas, Inc. | 2.259 B USD | 33.02 USD | +2.12% | 672.024 K | 1.20 | — | −5.93 USD | −4.89% | 0.00% | Health Technology | Strong buy |
 MYGNMyriad Genetics, Inc. | 2.245 B USD | 24.80 USD | +0.57% | 364.587 K | 0.30 | — | −2.82 USD | −56.54% | 0.00% | Health Technology | Neutral |
 DCPHDeciphera Pharmaceuticals, Inc. | 2.201 B USD | 25.45 USD | 0.00% | 704.804 K | 0.34 | — | −2.21 USD | +5.92% | 0.00% | Health Technology | Neutral |
 KYMRKymera Therapeutics, Inc. | 2.176 B USD | 35.47 USD | −1.31% | 139.589 K | 0.27 | — | −2.50 USD | +12.88% | 0.00% | Health Technology | Buy |
 RCKTRocket Pharmaceuticals, Inc. | 2.128 B USD | 23.45 USD | −0.91% | 256.069 K | 0.53 | — | −2.87 USD | +14.46% | 0.00% | Health Technology | Strong buy |
 ZLABZai Lab LimitedDR | 2.119 B USD | 19.92 USD | −4.46% | 274.96 K | 0.26 | — | −3.50 USD | +18.13% | 0.00% | Health Technology | Strong buy |
 ADMAADMA Biologics Inc | 2.111 B USD | 9.11 USD | +0.05% | 702.632 K | 0.18 | — | −0.02 USD | +91.39% | 0.00% | Health Technology | Strong buy |
 AMPHAmphastar Pharmaceuticals, Inc. | 2.049 B USD | 41.89 USD | −1.30% | 107.21 K | 0.27 | 14.44 | 2.90 USD | +62.71% | 0.00% | Health Technology | Buy |
 AGIOAgios Pharmaceuticals, Inc. | 1.988 B USD | 35.02 USD | −0.45% | 71.108 K | 0.11 | — | −6.31 USD | −58.92% | 0.00% | Health Technology | Buy |
 BEAMBeam Therapeutics Inc. | 1.96 B USD | 23.81 USD | −1.24% | 201.654 K | 0.16 | — | −1.78 USD | +60.05% | 0.00% | Health Technology | Buy |
 KROSKeros Therapeutics, Inc. | 1.95 B USD | 54.03 USD | −0.68% | 60.261 K | 0.21 | — | −5.14 USD | −16.74% | 0.00% | Health Technology | Strong buy |
 GLPGGalapagos NVDR | 1.929 B USD | 29.66 USD | +1.99% | 79.056 K | 0.97 | — | −2.32 USD | −3035.40% | 0.00% | Health Technology | Buy |
 SANASana Biotechnology, Inc. | 1.924 B USD | 8.69 USD | −6.31% | 416.561 K | 0.18 | — | −1.53 USD | +9.44% | 0.00% | Health Technology | Buy |
 PTGXProtagonist Therapeutics, Inc. | 1.865 B USD | 31.80 USD | +1.05% | 99.708 K | 0.19 | 12.98 | 2.45 USD | — | 0.00% | Health Technology | Strong buy |
 NVAXNovavax, Inc. | 1.852 B USD | 13.19 USD | +2.25% | 9.626 M | 0.24 | — | −3.18 USD | +77.89% | 0.00% | Health Technology | Buy |
 ARDXArdelyx, Inc. | 1.829 B USD | 7.82 USD | −0.45% | 659.316 K | 0.09 | — | −0.29 USD | +27.52% | 0.00% | Health Technology | Strong buy |
 FUSNFusion Pharmaceuticals Inc. | 1.828 B USD | 21.50 USD | −0.21% | 105.575 K | 0.27 | — | −1.42 USD | +28.83% | 0.00% | Health Technology | Neutral |
 VCYTVeracyte, Inc. | 1.823 B USD | 23.84 USD | +1.23% | 168.561 K | 0.21 | — | −0.93 USD | −122.18% | 0.00% | Health Technology | Buy |
 INBXInhibrx, Inc. | 1.809 B USD | 34.52 USD | +0.42% | 211.85 K | 0.33 | — | −5.35 USD | −35.87% | 0.00% | Health Technology | Neutral |
 SNDXSyndax Pharmaceuticals, Inc. | 1.772 B USD | 20.86 USD | −4.95% | 546.26 K | 0.62 | — | −3.22 USD | −33.10% | 0.00% | Health Technology | Strong buy |
 KURAKura Oncology, Inc. | 1.722 B USD | 22.61 USD | +3.38% | 506.182 K | 0.86 | — | −2.18 USD | −6.72% | 0.00% | Health Technology | Strong buy |
 GPCRStructure Therapeutics Inc.DR | 1.682 B USD | 36.30 USD | +0.64% | 247.135 K | 0.52 | — | −2.31 USD | — | 0.00% | Commercial Services | Strong buy |